Veralto Work in process increased by 8.9% to $49.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.0%, from $43.00M to $49.00M. Over 3 years (FY 2022 to FY 2025), Work in process shows a downward trend with a -4.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $51.00M | $45.00M | $42.00M | $43.00M | $43.00M | $43.00M | $39.00M | $43.00M | $48.00M | $48.00M | $45.00M | $49.00M |
| QoQ Change | — | -11.8% | -6.7% | +2.4% | +0.0% | +0.0% | -9.3% | +10.3% | +11.6% | +0.0% | -6.3% | +8.9% |
| YoY Change | — | — | -17.6% | — | — | -4.4% | -7.1% | +0.0% | +11.6% | +11.6% | +15.4% | +14.0% |
| % of Inventories | 14.8% | 14.2% | 14.1% | 14.0% | 13.8% | 13.2% | 13.5% | 13.9% | 14.6% | 14.1% | 14.7% | 14.8% |
| Share Change | — | -0.5pp | -0.1pp | -0.2pp | -0.2pp | -0.6pp | +0.4pp | +0.3pp | +0.7pp | -0.5pp | +0.5pp | +0.1pp |